Jim Fink Investing

Publications

CAH, CRM, JPM, HUM, BAH: Surge and Dip

Jim Fink, Derek Myers / Rolls

Five rolls to finish up March (2nd week). Have a great weekend!… Read More


CAH, CRM, JPM, HUM, BAH: Surge and Dip

Jim Fink, Derek Myers / Rolls

Please Note: Five Separate Rolls   1(a). Closeout on Cardinal Health (NYSE: CAH) as Part of Vertical Roll “Buy to Close” March (2nd week) $113 Call Option Symbols: CAH240308C113 Limit Order Price: Net debit of $2.20 or less ($220 per option) – day order Tell your broker: I’d like to enter an option order on […]… Read More


NSC, RCL, SPY: Marching Along

Jim Fink / Rolls

Three rolls and one expiring winner: TSLA (16.3%)… Read More


NSC, RCL, SPY: Marching Along

Jim Fink / Rolls

Please Note: Three Separate Rolls   1. Vertical Roll on Royal Caribbean Cruises (RCL) to March (3rd week) “Buy to Close” March (2nd week) $125 Call and “Sell to Close” March (2nd week) $128 Call and “Buy to Open” March (3rd week) $131 Call and “Sell to Open” March (3rd week) $126 Call Option Symbols: […]… Read More


FCN, NEE, ROP: Triple Play

Jim Fink / New Trades

A market correction may come soon, but these three stocks will likely outperform regardless…. Read More


FCN, NEE, ROP: Triple Play

Jim Fink / New Trades

Please Note: Three Separate Trades Valid Through Monday March 18th   1. Put Credit Spread on FTI Consulting (NYSE: FCN) “Buy to Open” April $195 Put and “Sell to Open” April $200 Put Option Symbols: FCN240419P195 and FCN240419P200 Limit Order Price: Net credit of $1.35 or more ($135 per spread) – good ’til canceled (GTC) […]… Read More


DDOG, IWM, LRCX: Blowoff Phase

Jim Fink / New Trades

  Please Note: Three Separate Trades   1. Put Credit Spread on Lam Research (Nasdaq: LRCX) “Buy to Open” March (4th week) $970 Put and “Sell to Open” March (4th week) $975 Put Option Symbols: LRCX240322P970 and LRCX240322P975 Limit Order Price: Net credit of $2.50 or more ($250 per spread) — good ’til canceled (GTC) […]… Read More


DDOG, IWM, LRCX: Blowoff Phase

Jim Fink / New Trades

The S&P 500 has risen in 16 of the last 18 weeks and is due for a pause, but some stocks may just keep going higher…. Read More


MA, DGX: Charging for Diagnostics

Jim Fink, Derek Myers / New Trades

On February 5th, we wrote that the S&P 500 reached new all-time highs. Finally, last week the Nasdaq 100 marked its record-breaking achievement by attaining a new all-time high. It’s noteworthy that it took the Nasdaq 100 a span of 569 days to secure this milestone, positioning it as the fourth most extended duration on record without reaching an all-time high. This week we are going with a neutral double diagonal on Mastercard (MA) and a bull call spread on Quest Diagnostics (DGX)…. Read More


MA, DGX: Charging for Diagnostics

Jim Fink, Derek Myers / New Trades

Please Note: Two New Trades Valid Through Monday, March 11th   1. Double Diagonal on Mastercard (NYSE: MA) “Buy to Open” May $435 Put and “Sell to Open” April $445 Put and “Buy to Open” May $515 Call and “Sell to Open” April $505 Call Option Symbols: MA240517P435 and MA240419P445 and MA240517C515 and MA240419C505 Limit […]… Read More


1 84 85 86 87 88 422

Search Jim Fink Investing